secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aspire Biopharma Holdings, Inc. (ASBP)
CIK:        0001847345
Form:       8-K/A
Filed at:   2026-04-17T23:59:59+00:00
Accession:  0001493152-26-017145
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aspire Biopharma closes second tranche of $21M preferred offering; funds Dura Driver acquisition
--------------------------------------------------------------------------------

- Closed second tranche of Series A Convertible Preferred stock on April 15, 2026 for 12,500 shares and gross proceeds of ~$10M.
- Combined with first tranche (13,750 shares, $11M), total offering raises $21M before fees.
- Amended Certificate of Designation to increase authorized Series A shares from 25,000 to 30,000.
- Net proceeds to fund cash portion of proposed Dura Driver Control Systems acquisition and for general corporate purposes.
- RBW Capital Partners acting through Dawson James Securities acted as placement agent.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1847345/000149315226017145/0001493152-26-017145-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1847345/000149315226017145/form8-ka.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-017145

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer